98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.annder.2025.103416 | DOI Listing |
Travel Med Infect Dis
September 2025
Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust. London, UK; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Introduction: Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania. Disease phenotypes are heterogenous, and diagnosis is frequently delayed. Treatment is often challenging, and international guidelines recommend consultation with experts.
View Article and Find Full Text PDFJ Infect Dev Ctries
August 2025
Department of Emergency, Changhai Hospital, Naval Medical University, Shanghai, China.
Introduction: Nocardia spp. are Gram-positive, aerobic actinomycetes, which can cause pulmonary, primary cutaneous, and lymphocutaneous infections. However, severe pneumonia caused by Nocardia otitidiscaviarum has rare reported.
View Article and Find Full Text PDFKlin Mikrobiol Infekc Lek
June 2025
Department of Infectious Diseases and Travel Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic, e-mail:
Skin and soft tissue infections (SSTIs) represent a diverse spectrum of conditions, including erysipelas, cellulitis, cutaneous abscesses, necrotizing fasciitis, and myonecrosis. Erysipelas and cellulitis are the most common community-acquired SSTIs. Erysipelas is typically caused by pyogenic streptococci, while cellulitis often has a staphylococcal etiology.
View Article and Find Full Text PDFJ Mycol Med
August 2025
Department of Intensive Care Unit, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China. Electronic address:
With opportunistic fungal pathogens increasingly recognized as a global public health threat, the population at high risk for invasive fungal infections (IFIs) has expanded beyond traditionally immunocompromised individuals-such as those with malignancies, organ transplantation, diabetes mellitus, or acquired immunodeficiency syndrome (AIDS)-to include critically ill patients in intensive care units (ICUs) receiving invasive support and immunomodulatory therapies. Invasive aspergillosis (IA) is one of the most lethal opportunistic infections in this population, characterized by insidious onset, clinical heterogeneity, and a lack of specific signs, often resulting in delayed diagnosis. Disseminated or breakthrough aspergillosis carries an exceedingly high mortality rate.
View Article and Find Full Text PDFAnn Dermatol Venereol
August 2025
Allergology and Photobiology Department Université Grenoble Alpes, Dermatology,- CHU Grenoble Alpes, Grenoble, France; Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, Grenoble, France.